Biotechnology Synthetic Biology Law In Russia.

1. Introduction

Synthetic biology is an advanced branch of biotechnology that involves designing, constructing, modifying and redesigning biological systems, organisms, cells and genetic materials using engineering principles.

It combines genetic engineering, molecular biology, biotechnology, computational biology and bioinformatics to develop new biological products and systems.

Examples include:

Artificially designed microorganisms.

Synthetic DNA and RNA.

Engineered bacteria for pharmaceutical production.

Synthetic vaccines and biological medicines.

Genetically engineered plants and microorganisms.

Artificial biological circuits.

Engineered enzymes and proteins.

Synthetic organisms designed for industrial applications.

Gene-editing and genome-modification technologies.

In Russia, synthetic biology is regulated through a combination of genetic engineering legislation, biological safety legislation, environmental protection laws, pharmaceutical regulation, public health legislation and intellectual property laws.

An important legal distinction: Russia does not have a single comprehensive federal statute exclusively devoted to synthetic biology. Instead, synthetic biology activities are governed by existing laws dealing with genetic engineering, biological safety, environmental protection and biotechnology.

The principal legislation includes:

Federal Law No. 86-FZ of 5 July 1996 – State Regulation in the Field of Genetic Engineering Activities.

Federal Law No. 492-FZ of 30 December 2020 – Biological Safety in the Russian Federation.

Federal Law No. 7-FZ of 10 January 2002 – Environmental Protection.

Federal Law No. 52-FZ of 30 March 1999 – Sanitary and Epidemiological Welfare of the Population.

Federal Law No. 61-FZ of 12 April 2010 – Circulation of Medicines.

Federal Law No. 323-FZ of 21 November 2011 – Protection of Public Health.

Civil Code of the Russian Federation – Intellectual Property Protection.

A 2025 academic study published in Lex Russica specifically examined the development of synthetic biology regulation in Russia and identified biological threats, particularly the potential creation of pathogenic organisms, as an area requiring more specialised regulation.

ГАРАНТ+1

 

2. Constitutional Foundations of Synthetic Biology Regulation

The Russian Constitution provides the general constitutional framework for scientific research, biotechnology and biological safety.

Important provisions include:

Article 41 – Right to health protection

The State must protect public health. Synthetic biological products, engineered microorganisms and biotechnology-based medicines must therefore be developed and used consistently with applicable health protection requirements.

Article 42 – Right to a favourable environment

Citizens have a constitutional right to a favourable environment and reliable information about its condition.

This provision is relevant when synthetic organisms or engineered microorganisms may affect ecosystems, biodiversity, agriculture or natural resources.

Article 44 – Freedom of scientific and technical creativity

Scientific research and technological innovation receive constitutional protection.

However, scientific freedom does not provide unrestricted permission to conduct activities that endanger public health, biological safety or the environment.

Article 58 – Environmental protection obligations

Everyone has a duty to preserve nature and the environment and to treat natural resources carefully.

Consequently, synthetic biology regulation must balance scientific freedom, technological development, public health and environmental protection.

3. Federal Law No. 86-FZ of 1996: Genetic Engineering Activities

Principal legislation

The most important statutory foundation for synthetic biology in Russia is Federal Law No. 86-FZ, dated 5 July 1996.

It regulates genetic engineering activities, including the creation and use of genetically engineered organisms.

The law covers matters relating to:

Genetic engineering technologies.

Recombinant DNA and RNA.

Genetic modification of biological organisms.

Biological and environmental safety.

State supervision.

Registration of genetically engineered organisms.

Legal responsibilities for violations.

Article 2 defines genetic engineering through methods and technologies involving recombinant nucleic acids, isolation of genes, genetic manipulation and introduction of genetic material into other organisms.

CIS Legislation+1

 

A. Regulation of synthetic organisms

Synthetic biology may involve creating biological systems through extensive genetic modification.

Where the resulting organism falls within the statutory definition of a genetically engineered organism, Federal Law No. 86-FZ becomes relevant.

For example, a research institution developing an engineered microorganism for industrial biotechnology may have to comply with applicable genetic engineering safety requirements.

B. Safety requirements

The law establishes a safety framework for genetic engineering activities.

Researchers and organisations must consider:

Biological safety of laboratory personnel.

Protection of the public.

Prevention of accidental biological release.

Environmental protection.

Appropriate containment.

Compliance with applicable technical and sanitary requirements.

C. Registration and supervision

Genetically engineered organisms and relevant products intended for environmental release are subject to state registration where required by law.

The legal framework also provides for monitoring and state supervision.

D. Human genetic engineering

An important distinction is that Article 1 of Law No. 86-FZ excludes from its scope the procedure for genetic engineering activities and application of its methods to a human being, tissues and cells as part of the human organism.

Therefore, human gene therapy and other human genetic interventions cannot simply be treated as ordinary environmental GMO activities. They require consideration of the separate healthcare and medicines framework.

4. Federal Law No. 492-FZ of 2020: Biological Safety

Federal Law No. 492-FZ, dated 30 December 2020, establishes the general legal foundations of biological safety in Russia.

Its central objective is to protect the population and environment from dangerous biological factors and prevent biological threats.

Article 1 addresses concepts including:

Biological safety.

Biological risks.

Dangerous biological factors.

Biological threats.

Pathogenic biological agents.

CIS Legislation+1

Application to synthetic biology

This law is particularly important when synthetic biology involves potentially dangerous biological materials.

For example:

Development of microorganisms with potentially harmful characteristics.

Research involving pathogenic biological agents.

Synthetic biological systems presenting environmental risks.

Accidental release of dangerous biological materials.

Biological incidents arising from research activities.

State responsibilities

The legislation establishes a framework for:

Monitoring biological risks.

Preventing biological threats.

Coordinating government authorities.

Protecting public health.

Protecting animals and plants.

Responding to biological emergencies.

The significance of Law No. 492-FZ is that synthetic biology is not merely a matter of scientific innovation. It also raises questions of national biological security and public protection.

5. Environmental Protection Law and Synthetic Organisms

Federal Law No. 7-FZ of 10 January 2002, concerning environmental protection, is another important component of Russian synthetic biology regulation.

Article 50 is particularly relevant.

It prohibits the cultivation and breeding of plants and animals whose genetic programmes have been modified using genetic engineering methods and which contain genetic engineering material that could not result from natural processes, except for cultivation and breeding undertaken for examination and scientific research.

This restriction is important for synthetic biology applications involving engineered plants and animals.

Legal implications

A synthetic biology company developing an engineered agricultural organism must examine:

Whether the organism falls within the statutory definition.

Whether its proposed use is legally permitted.

Whether scientific research exceptions apply.

Whether environmental release requires registration.

Whether monitoring requirements apply.

The law therefore places environmental protection considerations alongside biotechnology development.

ГАРАНТ+1

6. Federal Law No. 358-FZ of 2016: Restrictions on Genetically Engineered Organisms

Federal Law No. 358-FZ of 3 July 2016 introduced important restrictions concerning genetically engineered plants and animals.

Its principal purpose was to strengthen state control over genetically engineered organisms and their environmental use.

The legislation introduced restrictions on:

Cultivation of genetically engineered plants.

Breeding of genetically engineered animals.

Importation and use of certain genetically engineered seeds.

Environmental release of genetically engineered organisms.

Monitoring the effects of genetically engineered products.

An exception exists for relevant scientific research and examination activities.

Relevance to synthetic biology

Suppose a Russian biotechnology company develops a synthetic organism designed to improve agricultural productivity.

If the organism falls within the applicable genetically engineered organism definitions, its cultivation may be restricted even if its intended purpose is economically beneficial.

The company cannot assume that technological innovation or commercial usefulness creates an exemption from GMO restrictions.

7. Registration of Synthetic Biology Products

Government Resolution No. 35 of 18 January 2023 establishes rules for state registration of genetically engineered organisms intended for environmental release and products obtained using or containing such organisms.

The registration framework includes:

Submission of relevant applications.

Examination of the organism or product.

Assessment of applicable safety information.

Registration where the legal requirements are satisfied.

Inclusion in the relevant state register.

Monitoring by competent authorities.

The framework assigns relevant responsibilities to Rospotrebnadzor, Rosselkhoznadzor and the Ministry of Health within their respective areas of competence.

CIS Legislation+1

 

Example: A company developing an engineered microorganism for environmental use must determine whether the organism and its proposed application require registration before release.

Importantly, not every synthetic biology laboratory experiment automatically requires the same environmental-release registration. The organism, intended purpose and applicable statutory provisions must be examined separately.

8. Sanitary and Epidemiological Regulation

Federal Law No. 52-FZ of 30 March 1999 regulates sanitary and epidemiological welfare.

It is relevant to synthetic biology laboratories, manufacturing facilities and biotechnology research institutions.

Important regulatory concerns

A. Laboratory safety

Research facilities must comply with applicable sanitary requirements.

B. Personnel protection

Organisations must protect employees from biological hazards.

C. Biological contamination

Facilities must take appropriate measures to prevent contamination and exposure.

D. Public health protection

Synthetic biological products must not create unacceptable risks to human health.

E. Government supervision

Competent authorities may exercise sanitary supervision and take enforcement measures when applicable legal requirements are violated.

9. Pharmaceutical and Medical Synthetic Biology

Synthetic biology has significant applications in pharmaceutical manufacturing.

Examples include:

Recombinant therapeutic proteins.

Synthetic vaccines.

Engineered microorganisms used in drug production.

Gene-based medicines.

Advanced biological medicines.

Synthetic biological components used in diagnostics.

Two important laws govern this area.

A. Federal Law No. 61-FZ of 2010 – Circulation of Medicines

This law regulates the circulation of medicines in Russia.

It addresses:

State registration of medicines.

Pharmaceutical manufacturing.

Quality control.

Safety assessment.

Clinical trials.

Pharmaceutical supervision.

Post-marketing monitoring.

A medicine developed using synthetic biology does not automatically become exempt from ordinary pharmaceutical requirements.

B. Federal Law No. 323-FZ of 2011 – Protection of Public Health

This law provides the general legal framework for medical activities and healthcare.

Synthetic biology-based medical interventions must be considered in light of:

Patient rights.

Informed consent.

Medical confidentiality.

Clinical research requirements.

Medical professional responsibilities.

Protection of patient health.

Example

A Russian biotechnology company develops a synthetic biological platform for producing a therapeutic protein.

Before commercial distribution, the relevant medicinal product must satisfy applicable registration, manufacturing, quality and safety requirements.

The fact that the manufacturing platform uses synthetic biology does not replace the pharmaceutical approval process.

10. Genetic Data, Privacy and Synthetic Biology

Synthetic biology increasingly depends on genetic information and computational biological systems.

Genetic data may reveal information about:

Individual biological characteristics.

Inherited conditions.

Genetic relationships.

Population characteristics.

Biological ancestry.

Medical predispositions.

Russia regulates personal data through Federal Law No. 152-FZ of 27 July 2006.

Genetic information may also fall within the special-category personal data framework where it reveals information about health.

Important development: Federal Law No. 43-FZ of 2026

The February 2026 amendments to Federal Law No. 86-FZ introduced additional provisions concerning human genetic data and its transfer.

The amendments address:

Genetic data of individuals.

Population genetic and immunological research.

Transfer of genetic information.

Legal conditions governing genetic-data handling.

The amendments also clarify that the genetic data framework is connected to the broader regulation of genetic engineering activities.

CIS Legislation+1

 

Legal significance

A synthetic biology research institution collecting human genetic information must examine:

Whether the information constitutes personal data.

Whether the research has an appropriate legal basis.

Whether consent is required.

Whether confidentiality obligations apply.

Whether cross-border data-transfer restrictions apply.

This is particularly important for international synthetic biology research collaborations.

11. Intellectual Property Rights in Synthetic Biology

Synthetic biology creates important intellectual property questions.

A biotechnology company may develop:

New synthetic DNA sequences.

Engineered microorganisms.

Novel biological production methods.

Modified enzymes.

Synthetic proteins.

Biological manufacturing platforms.

The Russian Civil Code, particularly Part IV, establishes the intellectual property framework.

A. Patent protection

Russian patent law may protect qualifying inventions involving biotechnology.

However, patentability depends on statutory requirements, including:

Novelty.

Inventive step.

Industrial applicability.

Compliance with exclusions from patent protection.

B. Biological inventions

Patent protection may be available for qualifying technical solutions involving biological materials and processes.

Nevertheless, the mere discovery of a naturally existing biological substance or sequence does not automatically establish a patentable invention.

C. Ownership of research inventions

Disputes may arise between:

Universities and researchers.

Biotechnology companies and employees.

Research institutions and investors.

Pharmaceutical companies and technology developers.

The ownership question depends on the applicable Civil Code provisions, employment arrangements, research agreements and intellectual property contracts.

D. Commercial confidentiality

Synthetic biology companies may also protect confidential technical information through trade-secret and contractual mechanisms.

12. International Legal Framework

Russian synthetic biology regulation also needs to be understood in its international context.

Important international instruments and frameworks include:

A. Convention on Biological Diversity, 1992

This convention provides an international framework for biodiversity conservation, sustainable use and benefit-sharing.

B. Cartagena Protocol on Biosafety, 2000

The protocol establishes an international biosafety framework concerning the transboundary movement, handling and use of living modified organisms.

Its applicability must be assessed in light of the treaty's membership and legal status for the relevant State.

C. Nagoya Protocol, 2010

It addresses access to genetic resources and the fair and equitable sharing of benefits arising from their utilisation, subject to applicable treaty obligations.

D. Biological and Toxin Weapons Convention, 1972

This convention is particularly relevant to synthetic biology because it prohibits biological and toxin weapons.

It is relevant to concerns about the misuse of biological technologies for hostile purposes.

International regulatory challenge

Synthetic biology products may be developed in one country, manufactured in another and distributed internationally.

This creates legal questions involving:

Biological safety.

Genetic resource access.

International research cooperation.

Technology transfer.

Intellectual property.

Export controls.

Cross-border movement of biological materials.

13. Government Authorities Responsible for Synthetic Biology Regulation

AuthorityPrincipal responsibility
Ministry of HealthMedical and pharmaceutical regulation
RospotrebnadzorSanitary and public health supervision
RosselkhoznadzorVeterinary and phytosanitary supervision
Ministry of Science and Higher EducationScientific research and research policy
Ministry of Natural ResourcesEnvironmental policy
RosprirodnadzorEnvironmental supervision
Federal Service for Intellectual Property (Rospatent)Patent and intellectual property administration

The precise authority depends on the nature of the synthetic biology activity.

14. Criminal and Administrative Liability

Synthetic biology activities may result in administrative or criminal liability when they violate applicable Russian legislation.

A. Administrative liability

The Code of Administrative Offences contains provisions relevant to biotechnology violations.

Article 6.3.1 is particularly important.

It addresses violations of genetic engineering legislation involving:

Use of unregistered genetically engineered organisms where registration is required.

Use beyond authorised purposes.

Violation of special conditions of use.

Use of products whose registration has expired.

For legal entities, the statutory penalty under the provision applicable to the 2023 case discussed below ranged from 100,000 to 500,000 roubles.

B. Environmental liability

Unlawful environmental release, contamination or harmful biological activities may also attract applicable environmental and administrative consequences.

C. Criminal liability

Depending on the conduct and circumstances, relevant provisions of the Criminal Code may apply, including provisions dealing with:

Environmental crimes.

Violations of sanitary and epidemiological rules.

Creation of biological threats.

Illegal handling of dangerous biological materials.

Biological terrorism or other prohibited conduct.

Criminal liability is not automatic merely because an organisation conducts synthetic biology research. The elements of the particular criminal offence must be established.

15. Important Case Laws Relating to Synthetic Biology in Russia

An important research limitation must be recognised: Russian courts have not yet developed a substantial body of reported judgments specifically concerning synthetic biology as a distinct legal discipline.

Nevertheless, decisions concerning genetically engineered organisms, environmental protection, biological safety and medical confidentiality provide useful legal principles.

Case 1. Supreme Court of the Russian Federation – 19 September 2023

Directly relevant GMO precedent

Case No.: 9-АД23-12-К1

Subject: Use of unregistered genetically engineered rapeseed.

Facts:

The case concerned a company operating agricultural land in the Nizhny Novgorod region.

During an inspection, authorities discovered genetically engineered rapeseed containing the CP4 EPSPS genetic element.

The company had used the seeds on agricultural fields without the required state registration.

The authorities imposed an administrative fine of 250,000 roubles.

Legal issues:

Whether the company had violated genetic engineering legislation.

Whether the genetically engineered material required registration.

Whether its agricultural use was permitted.

Whether administrative liability could be imposed.

Judgment:

On 19 September 2023, the Supreme Court rejected the company's challenge and upheld the previous decisions.

The Court recognised that the use of unregistered genetically engineered organisms, where registration was legally required, constituted an administrative violation.

Legal principles:

Genetically engineered organisms must comply with applicable registration requirements.

Agricultural use cannot be justified merely by commercial objectives.

Regulatory authorities can rely on scientific testing and inspection evidence.

Businesses must comply with statutory restrictions on genetically engineered organisms.

Relevance to synthetic biology:

This decision is important for synthetic biology companies developing engineered agricultural organisms.

If a synthetic organism falls within the applicable GMO legislation, failure to comply with registration and authorised-use requirements may result in administrative penalties.

Source:

ГАРАНТ+1

 

Case 2. Avilkina and Others v. Russia (2013)

Court: European Court of Human Rights.

Subject: Medical confidentiality and disclosure of personal health information.

Facts:

The case concerned the disclosure of confidential medical information to public authorities without the applicants' consent.

The dispute raised questions concerning the protection of private medical information.

Legal issue:

Whether disclosure of confidential medical information violated the right to respect for private life under Article 8 of the European Convention on Human Rights.

Legal significance:

The case illustrates the importance of confidentiality in medical and health-related information.

Relevance to synthetic biology:

Synthetic biology research involving human genetic samples and identifiable genetic information raises similar privacy concerns.

However, this case is not a direct ruling on synthetic biology or genetic engineering.

Its value is in understanding the broader legal protection of confidential medical information.

Case 3. Roman Zakharov v. Russia (2015)

Court: European Court of Human Rights.

Subject: Privacy and safeguards against unlawful surveillance.

Facts:

The applicant challenged the Russian system of communications interception and the safeguards governing surveillance.

Legal issue:

Whether the legal framework provided adequate protection against arbitrary interference with private life under Article 8 of the European Convention on Human Rights.

Legal principle:

State interference with private communications must be subject to adequate legal safeguards.

Relevance to synthetic biology:

The decision provides a broader privacy-law reference for research involving large genetic databases, biological identification systems and sensitive genetic information.

It does not directly determine the legality of synthetic biology research.

Case 4. Supreme Court of the Russian Federation – GMO Registration Disputes

The 2023 decision discussed above is especially significant because it demonstrates how Russian courts apply statutory registration requirements in practice.

Its importance extends beyond conventional agricultural biotechnology.

Synthetic biology companies may face similar questions when developing:

Engineered microorganisms.

Modified biological production systems.

Synthetic organisms intended for environmental release.

Genetically modified agricultural materials.

The decisive issue is whether the particular organism or activity falls within the applicable statutory definitions and registration requirements.

Overall assessment of Russian case law

Legal issueJudicial position
Unregistered GMOsDirect Supreme Court precedent exists
Environmental releaseStatutory restrictions are enforceable
Synthetic microorganismsLimited specifically reported case law
Synthetic genomesNo established specialised precedent identified
Human gene editingSeparate medical and legal framework
Genetic-data privacyGeneral privacy jurisprudence is relevant
Synthetic biology patentsGeneral patent law applies

These authorities should not be described as a developed body of synthetic-biology-specific case law.

16. Synthetic Biology and National Security in Russia

National security is an important dimension of Russian synthetic biology regulation.

Synthetic biology can be used for beneficial purposes, but certain applications may also create biological security risks.

Examples include:

Modification of pathogenic biological agents.

Creation of organisms with potentially dangerous properties.

Misuse of synthetic biological materials.

Unauthorised biological experimentation.

Development of biological agents for prohibited purposes.

Russia's updated policy framework on chemical and biological safety has expressly addressed synthetic biology technologies and the potential creation of pathogens.

A Russian parliamentary commission report has also identified the design and creation of pathogens using synthetic biology technologies as a biological security concern.

russiancouncil.ru+1

 

Legal consequences

The national security dimension may involve:

Government supervision of potentially dangerous biological research.

Monitoring biological threats.

Protection of biological research infrastructure.

Control of dangerous biological materials.

Prevention of unlawful biological activities.

Interagency coordination during biological emergencies.

This means that the legal treatment of synthetic biology may differ considerably depending on whether the research concerns ordinary industrial biotechnology or potentially dangerous biological applications.

17. Major Legal Challenges in Synthetic Biology Regulation

Russia faces several important regulatory challenges.

1. Absence of a dedicated synthetic biology statute

Existing legislation regulates genetic engineering and biotechnology generally. It does not comprehensively address every technology associated with synthetic biology.

2. Regulatory uncertainty concerning synthetic organisms

Some synthetic biological systems may not fit neatly into traditional GMO classifications.

This creates questions about the appropriate legal classification and applicable regulatory requirements.

3. Dual-use research

Technologies developed for medical or industrial purposes may potentially be misused.

The challenge is balancing legitimate scientific research with biological security.

4. Environmental release

Synthetic organisms released into natural environments may create ecological risks that are difficult to predict.

5. Human genetic research

Genetic engineering and synthetic biological applications involving human cells raise questions concerning consent, privacy, medical safety and human rights.

6. Intellectual property conflicts

Patent ownership, synthetic DNA sequences, engineered microorganisms and commercially valuable biological platforms may generate disputes.

7. International cooperation

Cross-border biological research raises questions concerning genetic data, research materials, export controls and international biosafety requirements.

8. Regulatory coordination

Different government agencies supervise different aspects of biotechnology. Coordination is therefore important to avoid gaps in oversight.

18. Suggestions for Legal Reform in Russia

A more comprehensive synthetic biology regulatory framework could address the following matters.

Proposed reformLegal objective
Dedicated synthetic biology legislationDefine the scope of regulated activities
Risk-based classificationDistinguish ordinary research from higher-risk activities
Synthetic organism registration rulesClarify registration requirements
Laboratory safety standardsStrengthen biological containment
Genetic-data safeguardsProtect genetic privacy
Dual-use research oversightAddress biological security risks
Environmental assessmentProtect biodiversity
Patent clarificationImprove protection of qualifying biological inventions
Research ethics standardsProtect human participants
International cooperation rulesClarify cross-border research obligations

A particularly important reform would be to distinguish conventional genetic engineering from advanced synthetic biology technologies without unnecessarily duplicating existing biotechnology regulation.

This approach is consistent with the regulatory-development proposals discussed in the 2025 Lex Russica academic study.

ГАРАНТ+1

 

19. Important Legislation and Case Law: Quick Reference

Legal authorityRelevance
Russian Constitution, Articles 41, 42, 44 and 58Health, environment, science and environmental duties
Federal Law No. 86-FZ (1996)Genetic engineering
Federal Law No. 52-FZ (1999)Sanitary safety
Federal Law No. 7-FZ (2002)Environmental protection
Federal Law No. 358-FZ (2016)GMO cultivation restrictions
Federal Law No. 61-FZ (2010)Pharmaceutical regulation
Federal Law No. 323-FZ (2011)Healthcare regulation
Federal Law No. 492-FZ (2020)Biological safety
Government Resolution No. 35 (2023)GMO registration
Federal Law No. 43-FZ (2026)Genetic-data amendments
Supreme Court Case No. 9-АД23-12-К1 (2023)Unregistered GMO use
Avilkina and Others v. Russia (2013)Medical confidentiality
Roman Zakharov v. Russia (2015)Privacy and surveillance

20. Conclusion

Synthetic biology law in Russia is developing through the interaction of genetic engineering regulation, biological safety legislation, environmental law, pharmaceutical regulation, privacy law and intellectual property protection.

Federal Law No. 86-FZ of 1996 provides the principal statutory foundation for genetically engineered organisms, while Federal Law No. 492-FZ of 2020 establishes the wider biological safety framework.

Federal Law No. 7-FZ of 2002 is particularly important for environmental protection and restrictions on genetically engineered plants and animals.

The 2023 Supreme Court decision in Case No. 9-АД23-12-К1 demonstrates that Russian authorities and courts can enforce GMO registration and authorised-use requirements through administrative proceedings.

The 2026 amendments under Federal Law No. 43-FZ also demonstrate the increasing importance of genetic information governance.

The central legal principle is that synthetic biology research is not automatically prohibited in Russia, but its legality depends on the organism, research purpose, biological risk, intended application and applicable regulatory requirements.

Russia's future regulatory challenge is to develop a sufficiently precise framework for advanced synthetic biological technologies while protecting scientific development, public health, environmental safety and national biological security.

21. Important Research Sources

For further academic and legal research:

Federal Law No. 86-FZ – Genetic Engineering Activities.

Federal Law No. 492-FZ – Biological Safety.

Federal Law No. 43-FZ of 2026 – Genetic Data Amendments.

Supreme Court Judgment No. 9-АД23-12-К1.

Development of Legal Regulation of Synthetic Biology: Integration and Legal Aspect – Lex Russica, 2025.

Russian Parliamentary Commission Report on Biological Security.

Academic note: This explanation reflects the legislative materials identified through 18 November 2026. For litigation or formal legal opinions, the current official Russian-language statutory texts and complete judicial decisions should be consulted. The European Court of Human Rights decisions discussed above are comparative human-rights authorities, not direct Russian synthetic biology judgments.

LawGratis provides pro bono legal aid and resources to empower communities. Join us in making justice reachable for everyone! Follow our community on Instagram, YouTube, Facebook, and LinkedIn.

LEAVE A COMMENT